Growth hormone receptor (ghr) RNAi decreases proliferation and enhances apoptosis in CMT-U27 canine mammary carcinoma cell line

Veterinary and Comparative Oncology

Volumn 10, Issue 1, 2012, Pages 2-15

  Pawlowski K M ^a   Popielarz, D ^a   Szyszko, K ^a   Gajewska, M ^a   Motyl, T ^a   Krol M ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Canine mammary cancer; Gene silencing; Growth hormone; Growth hormone receptor; SiRNA

Indexed keywords

GROWTH HORMONE RECEPTOR;

ANALYSIS OF VARIANCE; ANIMAL; ANIMAL DISEASE; APOPTOSIS; ARTICLE; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; NUCLEIC ACID DATABASE; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; DATABASES, NUCLEIC ACID; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; RECEPTORS, SOMATOTROPIN; RNA INTERFERENCE;

EID: 84857034996     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2011.00269.x     Document Type: Article

References (44)

1. Selman PJ, Mol JA, Rutteman GR, van Garderen E and Rijnberk A. Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology 1994; 134: 287-292.
2. Mol JA, Van Garderen E, Selman PJ, Wolfswinkel J, Rijnberk A and Rutteman GR. Growth hormone mRNA in mammary gland tumors of dogs and cats. The Journal of Clinical Investigation 1995; 95: 2028-2034.
3. Liu N, Mertani HC, Norstedt G, Tornell J and Lobie PE. Mode of the autocrine/paracrine mechanism of growth hormone action. Experimental Cell Research 1997; 237: 196-206.
4. Garderen van E, De Wit M, Voorhout WF, Rutteman GR, Mol JA, Nederbragt H and Misdorp W. Expression of growth hormone in canine mammary tissue and mammary tumors. Evidence for a potential autocrine/paracrine stimulatory loop. American Journal of Pathology 1997; 150: 1037-1047.
5. Garderen van E, Poel van der HJA, Swennenhuis JF, Wissink EHJ, Rutteman GR, Hellmen E, Mol JA and Schalken JA. Expression and molecular characterization of the growth hormone receptor in canine mammary tissue and mammary tumors. Endocrinology 1999; 140: 5907-5914.
6. Jenkins PJ, Mukherjee A and Shalet SM. Does growth hormone cause cancer? Clinical Endocrinology 2006; 64: 115-121.
7. Król M, Pawłowski KM, Skierski J, Turowski P, Majewska A, Polańska J, Ugorski M, Morty RE and Motyl T. Transcriptomic "portraits" of canine mammary cancer cell lines with various phenotype. Journal of Applied Genetics 2010; 51: 169-183.
8. Skolowski JH. False pregnancy. The Veterinary Clinics of North America 1982; 12: 93-98.
9. Jochle W, Heim U and Heim G. Pseudopregnancy in the bitch and its treatment with cabergoline. Kleinter-praxix 1994; 39: 561-566.
10. Johnson SD, Root Kustritz MV and Olson PN. False pregnancy/galactorrhea. In: Canine and Feline Theriogenology, 3rd edn., R Kersey, ed., Philadelphia, Saunders, 2001; 243-256.
11. Davis DL and Bradlow HL. Can environmental estrogens cause breast cancer? Scientific American 1995; 273: 167-172.
12. Rutteman GR, Willekes-Koolschijn N, Bevers MM, van der Gugten AA and Misdorp W. Prolactin binding in benign and malignant mammary tissue of female dogs. Anticancer Research 1996; 6: 829-835.
13. Rutteman GR. Contraceptive steroids and the mammary gland: is there a hazard? Insights from animal studies. Breast Cancer Research and Treatment 1992; 23: 29-41.
14. Misdorp W. Progestagens and mammary tumors in dogs and cats. Acta Endocrinologica (Copenhagen) 1991; 125: 27-31.
15. Lantinga-van Leeuwen IS, van Garderen E, Rutteman GR and Mol JA. Cloning and cellular localization of the canine progesterone receptor: co-localization with growth hormone in the mammary gland. The Journal of Steroid Biochemistry and Molecular Biology 2000; 75: 219-228.
16. Mol JA, Garderen van E, Rutteman GR and Rijnberk A. New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: induction of the local biosynthesis of growth hormone (GH) in the mammary gland of dogs, cats and humans. The Journal of Steroid Biochemistry and Molecular Biology 1996; 57: 67-71.
17. Millanta F, Calandrella M, Bari G, Niccolini M, Vannozzi I and Poli A. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Research in Veterinary Science 2005; 79: 225-232.
18. Rao NAS, Wolferen van ME, Gracanin A, Bhatti SFM, Król M, Holstege FC and Mol JA. Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. Journal of Physiology and Pharmacology 2009; 60: 73-84.
19. Król M, Pawłowski KM, Skierski J, Rao NAS, Hellmen E, Mol JA and Motyl T. Transcriptomic profile of two canine cancer cell lines with different proliferative and anti-apoptotic potential. Journal of Physiology and Pharmacology 2009; 60: 95-106.
20. Pollak MN, Schernhammer ES and Hankinson SE. Insulin-like growth factors and neoplasia. Nature Reviews Cancer 2004; 4: 505-518.
21. Carter-Su C, Rui L and Herrington J. Role of the tyrosine kinase JAK2 in signal transduction by growth hormone. Pediatric Nephrology 2000; 14: 550-557.
22. Zhu T, Goh EL, Graichen R, Ling L and Lobie PE. Signal transduction via the growth hormone receptor. Cellular Signalling 2001; 13: 599-616.
23. Zhang W and Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Research 2002; 12: 9-18.
24. Kotev V. Dynamical behavior of a time delay model of the ERK and STAT5 interaction. Bioautomation 2007; 8: 123-132.
25. Hellmén E. Characterization of four in vitro established canine mammary carcinoma and one atypical benign mixed tumor cell lines. In Vitro Cellular & Development Biology 1992; 5: 309-319.
26. Hellmén E, Moller M, Blankenstein MA, Andersson L and Westermark B. Expression of different phenotypes in cell lines from canine mammary spindle-cell tumours and osteosarcomas indicating a pluripotent mammary stem cell origin. Breast Cancer Research and Treatment 2000; 61: 197-210.
27. Tschuiya F, Kano R, Sano J, Oguma K and Hasegawa A. Apoptosis of canine mammary tumor cells induced by small interfering RNA (siRNA) against Bcl-xL gene. The Journal of Veterinary Medical Science 2006; 68: 1199-1201.
28. Wieczorek M, Paczkowska A, Guzenda P, Majorek M, Bednarek A and Lamparska-Przybysz M. Silencing of Wnt-1 by siRNA induces apoptosis of MCF-7 human breast cancer cells. Cancer Biology & Therapy 2008; 7: 268-274.
29. Forbes K, Desforges M, Garside R, Aplin JD and Westwood M. Methods for siRNA-mediated reduction of mRNA and protein expression in human placental explants, isolated primary cells and cell lines. Placenta 2009; 30: 124-129.
30. Bhatti SFM, Rao NAS, Okkens AC, Mol JA, Duchateau L, Ducatelle R, Ingh van den TSGAM, Tshamala M, Ham van LML, Coryn M, Rijnberk A and Kooistra HS. Role of progestin-induced mammary-derived growth hormone in the pathogenesis of cystic endometrial hyperplasia in the bitch. Domestic Animal Endocrinology 2007; 33: 294-312.
31. Brinkhof B, Spee B, Rothuizen J and Penning LC. Development and evaluation of canine reference genes for accurate quantification of gene expression. Analytical Biochemistry 2006; 356: 36-43.
32. Etschmann B, Wilcken B, Stoevesand K, Schulenburg von der A and Sterner-Kock A. Selection of reference genes for quantitative real-time PCR analysis in canine mammary tumors using the GeNorm algorithm. Veterinary Pathology 2006; 43: 934-942.
33. Schmittgen TD and Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nature Protocols 2008; 3: 1101-1108.
34. Sadava D and Hamman W. RNA interference against MDR1 but not MRP1 reverses drug resistance in human small-cell lung cancer cells. Journal of Cancer Molecules 2007; 3: 91-94.
35. Faltus T, Yuan J, Zimmer B, Kramer A, Loibl S, Kaufmann M and Strebhardt K. Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells. Neoplasia 2004; 6: 786-795.
36. Mittendorf EA, Liu Y, Tucker SL, McKenzie T, Qiao N, Akli S, Biernacka A, Liu Y, Meijer L, Keyomarsi K and Hunt KK. A novel interaction between HER2/neu and cyclin E in breast cancer. Oncogene 2010; 29: 3896-3907.
37. Melrose Z, Eltobgi A, Abbott L, Munir A and Nowell-Price J. Targeting growth hormone by RNA interference: implications for acromegaly. Endocrine Abstracts 2008; 15: P257.
38. Bonetta L. RNAi: silencing never sounded better. Nature Methods 2004; 1: 79-86.
39. Khvorova A, Reynolds A and Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003; 115: 209-216.
40. Kaulsay KK, Zhu T, Bennett WF, Lee KO and Lobie PE. The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor. Endocrinology 2001; 142: 767-777.
41. Vasilcanu R, Vasilcanu D, Sehat B, Yin S, Girnita A, Axelson M and Girnita L. Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin. Molecular Pharmacology 2008; 73: 930-939.
42. Baserga R. Oncogenes and the strategy of growth factors. Cell 1994; 79: 927-930.
43. Schamberger CJ, Gerner C and Cerni C. Caspase-9 plays a marginal role in serum starvation-induced apoptosis. Experimental Cell Research 2005; 302: 115-128.
44. Costoya JA, Finidori J, Moutoussamy S, Senaris R, Devesa J and Arce VM. Activation of growth hormone receptor delivers an antiapoptotic signal: evidence for a role of Akt in this pathway. Endocrinology 1999; 140: 5937-5943.